Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure
نویسندگان
چکیده
منابع مشابه
Is diastolic heart failure synonymous with heart failure with preserved ejection fraction?
1. Tang WHW, Francis GS, Hoogwerf BJ, Young JB. Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure. J Am Coll Cardiol 2003;41:1394–8. 2. Larsen TM, Toubro S, Astrup A. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord 2003;27:147–61.
متن کاملMetformin and thiazolidinedione use in Medicare patients with heart failure.
CONTEXT According to package inserts, metformin is contraindicated in diabetic patients receiving drug treatment for heart failure therapy, and thiazolidinediones are not recommended in diabetic patients with symptoms of advanced heart failure. Little is known about patterns of use of these antihyperglycemic drugs in diabetic patients with heart failure. OBJECTIVE To determine the proportions...
متن کاملChanges in the structure of the heart and blood pressure after a period of concurrent endurance-resistance training in patients with chronic heart failure
Background: Exercise improves functional capacity by improving endothelial function and musculoskeletal aerobic metabolism, but its effects on hemodynamic control are not well known. The aim of this study was to investigate the effect of aerobic and resistance trainings on structural changes and blood pressure in patients with heart failure. Materials and methods: 76 patients aged 65 to 79 year...
متن کاملThiazolidinedione Use, Fluid Retention, and Congestive Heart Failure A Consensus Statement From the American Heart Association and American Diabetes Association
Diabetes is a chronic, progressively worsening disease associated with a variety of microvascular and macrovascular complications. Cardiovascular disease (CVD) is the main cause of death in these patients.1,2 During the past decade, numerous drugs have been introduced for the treatment of type 2 diabetes that, used in monotherapy or in combination therapy, are effective in lowering blood glucos...
متن کاملStem Cell Therapy in Patients with Chronic Nonischemic Heart Failure
Aim of the Review The aim of this review is to discuss recent advances in clinical aspects of stem cell therapy in chronic nonischemic heart failure (DCMP) with emphasis on patient selection, stem cell types, and delivery methods. Recent Findings Several stem cell types have been considered for the treatment of DCMP patients. Bone marrow-derived cells and CD34+ cells have been demonstrated to...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2003
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(03)00159-1